Biosyn Arzneimittel GmbH is one of the first German biotechnology companies. Since its founding in 1984, it has developed into a pharmaceutical enterprise with over 70 employees, supplying customers in over 20 countries. There are Biosyn subsidiaries in Liechtenstein, Austria and the USA. With selenase®, this hidden champion is a global market leader in selenium injection solutions for treating sepsis, selenium deficiency and thyroid diseases. Immucothel®, Biosyn’s Keyhole Limpet Hemocyanin (KLH) ethically extracted from living so urces, is a virtually side-effect-free adjuvant licensed for bladder cancer therapy.Biosyn Pharma supplies the entire range of biosyn products for oncology, immunology, endocrinology and intensive care medicine.